Health economic consequences of resuming anticoagulation after intracranial hemorrhage in patients with atrial fibrillation

Anne Sig Vestergaard; Flemming Skjøth; Professor Gregory Lip; Torben Bjerregaard Larsen

Related publications

Article2017

Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation

Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth, Professor Gregory Lip

Article2016

Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation

Anne Sig Vestergaard, Flemming Skjøth, Professor Gregory Lip, Torben Bjerregaard Larsen

Article2019

Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage

So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2025

Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage

Wulamiding Kaisaier, Chaokun Guan, Min Ye, Siyu Guo, Yili Chen, Yugang Dong, Professor Gregory Lip, Chen Liu, Wengen Zhu

Article2019

Anticoagulation After Stroke in Patients With Atrial Fibrillation

Riccardo Altavilla, Valeria Caso, Fabio Bandini, Giancarlo Agnelli, Georgios Tsivgoulis, Shadi Yaghi, Karen L. Furie, Prasanna Tadi, Cecilia Becattini, Marialuisa Zedde, Azmil H. Abdul‐Rahim, Kennedy R. Lees, Andrea Alberti, Michele Venti, Monica Acciarresi, Cataldo D’Amore, Maria Giulia Mosconi, Ludovica Anna Cimini, Jessica Fusaro, Paolo Bovi, Monica Carletti, Alberto Rigatelli, Manuel Cappellari, Jukka Putaala,